Trials / Completed
CompletedNCT02860585
Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 235 (actual)
- Sponsor
- Institut Paoli-Calmettes · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to evaluate the outcome of patients affected with different subtypes of metastatic breast cancer following treatment with high-dose chemotherapy and autologous haematopoietic progenitor cell transplantation.
Conditions
Timeline
- Start date
- 2013-09-27
- Primary completion
- 2016-02-29
- Completion
- 2016-02-29
- First posted
- 2016-08-09
- Last updated
- 2017-09-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02860585. Inclusion in this directory is not an endorsement.